ABITUZUMAB
UNII 724QD330RD

Substance Identification & Data

This profile provides standardized clinical and technical data for Abituzumab, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 724QD330RD.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 1105038-73-0 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
724QD330RD
CAS Registry Number
1105038-73-0
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
ABITUZUMAB
Official standardized name for this substance within the FDA UNII nomenclature system.
NCI Thesaurus
National Cancer Institute reference terminology for clinical and research data.
INN ID
9509
Sequential identifier assigned via the WHO International Nonproprietary Name program.
Substance Type
protein
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Abituzumab. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

ABITUZUMAB

Common Names & Synonyms

ABITUZUMAB [INN]
ABITUZUMAB [WHO-DD]
IMMUNOGLOBULIN G2-KAPPA, ANTI-(HOMO SAPIENS ITGAV (INTEGRIN ALPHAV, CD51)), HUMANIZED MONOCLONAL ANTIBODY

Technical Codes

DI 17E6
DI17E6
DI-17E6
EMD 525797
EMD-525797